CLOCK and central nervous system cancer: The authors found no significant differences in progression-free survival (PFS), overall survival (OS), and treatment toxicity between the two treated groups, which implies that either high-grade gliomas are less responsive to the time-based delivery of the radiotherapy, or that the patients in the different groups (morning vs afternoon) were not treated at their optimal treatment time, according to their circadian clock.